SANDHOFF DISEASE
Clinical trials for SANDHOFF DISEASE explained in plain language.
Never miss a new study
Get alerted when new SANDHOFF DISEASE trials appear
Sign up with your email to follow new studies for SANDHOFF DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for rare brain diseases: experimental drug venglustat tested in phase 3 trial
Disease control TerminatedThis study tested an experimental drug called venglustat in adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that damage the brain and nerves. The goal was to see if daily pills could slow the disease by reducing harmful fatty buildup. The…
Matched conditions: SANDHOFF DISEASE
Phase: PHASE3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Experimental gene therapy targets rare fatal brain diseases in kids
Disease control TerminatedThis study tested a gene therapy called AXO-AAV-GM2 in children with Tay-Sachs or Sandhoff disease, rare and fatal genetic disorders that damage the brain. The therapy aimed to deliver healthy genes to brain cells to restore a missing enzyme. The trial enrolled up to 9 children a…
Matched conditions: SANDHOFF DISEASE
Phase: PHASE1 • Sponsor: Terence Flotte • Aim: Disease control
Last updated May 12, 2026 13:41 UTC